IND Swift Laboratories Ltd

INDSWFTLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹470 cr, stock is ranked 1,241
High RiskStock is 4.12x as volatile as Nifty
79.553.75 (+4.95%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹470 cr, stock is ranked 1,241
High RiskStock is 4.12x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-149.22
PB RatioPB Ratio
0.78
Dividend YieldDiv. Yield
Sector PESector PE
38.74
Sector PBSector PB
5.18
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ind-Swift Laboratories Limited is a company focused on the development of active pharmaceutical ingredients (APIs).

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021784.01876.44813.04914.0421.9628.94-21.19-3.15
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnNov 9, 2021

Ind-Swift Laboratories Limited has informed the Exchange regarding 'Intimation of Record Date for Payment of Interest to holders of Non Convertible Debentures'. | Download

Ind-Swift Laboratories Limited has informed the Exchange regarding 'Intimation of Record Date for Payment of Interest to holders of Non Convertible Debentures'. | Download

Copy of Newspaper Publication 
Announced OnNov 2, 2021

Ind-Swift Laboratories Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results | Download

Ind-Swift Laboratories Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results | Download

Cash Dividend 
Ex. DateSep 20, 2011

Final • Div/Share: ₹ 1

See all events